off label use of semaglutide Off-Label Linked to Deaths, Hospitalizations Calling for Compounding Regulation FDA adds warning for intestinal

Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS

In its initial announcements, CMS indicated that the GLP-1 Bridge program would run from July 1, 2026, through the end of the year, with the BALANCE Model beginning in January 2027

Patients should follow package directions and not exceed recommended maximum daily doses (e.g., no more than 3,000 mg of acetaminophen daily)

Presented for research literature review only Ballatori N et al

A GP can arrange basic investigations including a full blood count, thyroid function tests, and iron studies to exclude common treatable causes